Se connecter

Recherches récentes

Aucune recherche récente

Options de recherche

Disponible uniquement lorsque vous êtes connecté.
framapiaf.org est l'un des nombreux serveurs Mastodon indépendants que vous pouvez utiliser pour participer au fédiverse.
Un service Mastodon fourni par l'association d’éducation populaire Framasoft.

Administré par :

Statistiques du serveur :

1,4K
comptes actifs

framapiaf.org: À proposÉtatAnnuaire des profilsPolitique de confidentialité

Mastodon: À proposTélécharger l’applicationRaccourcis clavierVoir le code sourcev4.3.7

#COVID

102 messages78 participants6 messages aujourd’hui
Public *
Mania Emma

Bonjouuur👋🏻😊

Voilà, j’ai digéré la tornade émotionnelle de la semaine dernière 😮‍💨

Et donc si vous connaissez des gens hyper fatigués, qui ont une maladie du genre le Syndrome d’Elhers-Danlos, la fibromyalgie ou le COVID long, sachez qu’il s’agit d’un ADN « traumatisé » (« méthylé »).
C’est éventuelle atténuable avec du « bon traitement » aka arrêter d’être maltraitée.

La science commence enfin à pouvoir le prouver papers.ssrn.com/sol3/papers.cf
Une psy spécialisée dans les traumatismes devrait pouvoir vous aider 🙏🏻

papers.ssrn.comMTHFR and LC, CFS, POTS, MCAS, SIBO, EDS: Methylating the AlphabetLong Covid (LC), Chronic Fatigue Syndrome (CFS), Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), Small Intestine Bacteri
#SEDh#fibromyalgie#covid
Public
Tom Kindlon

ICU participants' hospitalisation conferred them status as legitimate patients in ‘medically clear and understandable ways’ whereas LC participants' ‘patienthood’ was neither evidenced nor authenticated"
onlinelibrary.wiley.com/doi/10

Image is from latest Science for ME weekly update

@longcovid
#LongCovid #PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC
@covid19 #Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2

Health Expectations Rethinking ‘Recovery’: A Comparative Qualitative Analysis of Experiences of Intensive Care With COVID and Long Covid in the United Kingdom — Alice MacLean et al. "Key differences in ‘worlds of illness’ stemmed from the fact that ICU participants' hospitalisation conferred them status as legitimate patients in ‘medically clear and understandable ways’ whereas LC participants' ‘patienthood’ was neither evidenced nor authenticated in the same way."
Public
Tom Kindlon

From Germany:

Abnormal Coronary Vascular Response in Patients with #LongCOVID Syndrome – a Case-Control Study Using Oxygenation-Sensitive Cardiovascular Magnetic Resonance

sciencedirect.com/science/arti

Image is from latest Science for ME weekly update

Hashtags:
@longcovid
#PASC #PwLC #postcovid #postcovid19 #LC #Covidlonghaulers #PostCovidSyndrome #longhaulers #COVIDBrain #NeuroPASC

@covid19 #Coronavirus
#COVID19 #COVID #COVID_19 #COVIDー19 #SARSCoV2 #CovidIsNotOver
@auscovid19 #auscovid19

1/

Journal of Cardiovascular Magnetic Resonance Abnormal Coronary Vascular Response in Patients with Long COVID Syndrome – a Case-Control Study Using Oxygenation-Sensitive Cardiovascular Magnetic Resonance — Weberling et al. "This pilot study is the first to show a blunted hemodynamic and myocardial oxygenation response to vasoactive breathing maneuvers during Oxygenation-sensitive CMR in long COVID patients. This simple, non-invasive test may be the first to objectify complaints of affected patients and indicates evidence for the crucial role of the endothelium in the pathophysiology of long COVID."
Public
Verfassungklage@troet.cafe

#mRNA-Impstoff
#Forscher begeistert:

#Corona-Impfung zeigt unerwartete Wirkung

Jetzt zeigt sich: Die #mRNA-Impfungen schützen nicht nur gegen #Covid-19, sondern haben auch einen langfristigen Einfluss auf unsere #Gesundheit. In einer #Studie untersuchten Forscher der #Universität #Köln, wie unser #Immunsystem durch den #Impfstoff umprogrammiert wurde – im positivsten Sinne. Die Studie wurde jetzt im #Fachmagazin „ #MolecularSystemsBiology “ veröffentlichen:

morgenpost.de/ratgeber-wissen/

Berliner Morgenpost · Forscher begeistert: Corona-Impfung zeigt unerwartete WirkungPar Ferdinand Heimbach
Public
Tom Kindlon

The use of oral anticoagulation at the time of acute #COVID19 infection & subsequent development of #longCOVID / post-acute sequelae of #SARSCoV2 infection

link.springer.com/article/10.1

"We found no evidence that prevalent OAC at the time of acute #COVID_19 infection was associated with reduced risk of LC/#PASC”

@longcovid
#PwLC #PostCovidSyndrome #postcovid
#CovidBrain
@covid19 #COVIDー19 #COVID @novid@chirp.social #novid @novid@a.gup.pe #auscovid19

SpringerLinkThe use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection - Journal of Thrombosis and ThrombolysisLong COVID (LC) or post-acute sequelae of SARS-CoV-2 infection (PASC) is defined as ongoing, relapsing or new symptoms/conditions persisting after an acute COVID-19 infection. Given the potential role of oral anticoagulants (OAC) in treating thrombotic sequelae of LC/PASC, we investigated whether prevalent OAC use at the time of acute COVID-19 infection was associated with reduced development of LC/PASC. Retrospective cohort study within the TriNetx network. The primary cohort was defined as adults with a confirmed diagnosis of COVID-19. We defined OAC users as those who had received OACs (either direct-acting OACs [DOACs] or vitamin K antagonists [VKA]) in the preceding 3-months and non-users as those without OAC use within the previous 12-months. The primary outcome was a composite of 9 features associated with LC/PASC We identified 38,409 DOAC users, 19,243 VKA users, and 2,329,771 non-OAC users with acute COVID-19 infection. After successful propensity score matching (PSM), we found an increased risk of LC/PASC features in those receiving DOAC compared to non-OAC (HR [95% CI] 1.50 [1.35 to 1.68], p < 0.0001), and in VKA users compared to non-OACs (HR [95% CI] 1.98 [1.78 to 2.20], p < 0.0001), while DOAC users were at reduced risk compared to VKA users (HR [95% CI] 0.71 [0.62 to 0.81], p < 0.0001). We found no evidence that prevalent OAC at the time of acute COVID-19 infection was associated with reduced risk of LC/PASC. Further work is needed to understand whether there is a role for OAC therapy in the management of LC/PASC.
Public
Lorraine

change.org/p/make-monoclonal-a

following is a #PSA copy/paste from an account from a private Facebook group & since there are a lot of🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🍁🇨🇦🍁🇨🇦🍁🇨🇦🍁🇨🇦🍁🇨🇦🍁🇨🇦🍁🇨🇦here at zeroes…

For those of you in Canada, I urge you to contact Health Canada, your local Members of Parliament (MPs), your Premier, the Minister of Health, and the Public Health Agency of Canada (PHAC) to demand the reinstatement of monoclonal antibodies (mAbs) for immunocompromised individuals in Canada-specifically, Pemgarda from Invivyd. Currently, Pemgarda is the only mAb available in North America, and even then, only in the United States under Emergency Use Authorization (EUA). Reaching out directly to Invivyd to express interest in bringing this medication to Canada could also make a difference, by showing there is demand for Pemgarda in Canada and encouraging the company to pursue regulatory approval.
Together, we can ensure that no one is left behind in the fight against COVID-19.
Government & Regulatory Bodies:
Health Canada - Regulates drug approvals and expanded access programs.
Email: hcinfo.infosc@canada.ca
Phone: 1-866-225-0709
Public Health Agency of Canada (PHAC) - Oversees public health responses, including
COVID-19 policies.
Email: phac.covid19.aspc@canada.ca

Minister of Health - Kamal Khera
Email: kamal.khera@parl.gc.ca
Phone: 613-995-4984
Mail: House of Commons, Ottawa, ON K1A 0A6
Your Local Member of Parliament (MP) - MPs can advocate for policy changes and increased federal support for Long COVID treatments.
Find your MP here:
https://www.ourcommons. ca/Members/en/search
Your Premier - Premiers influence provincial healthcare policy and can push for access to Pemgarda at the provincial level.
• Ontario - Doug Ford
Email: premier@ontario.ca
Phone: 416-325-1941
• British Columbia - David Eby
Email: premier@gov.bc.ca
Phone: 250-387-1715
• Alberta - Danielle Smith
Email: premier@gov.ab.ca
Phone: 780-427-2251
• Quebec - François Legault
Email: premierministre@quebec.ca
Phone: 418-643-5321
Full list of provincial premiers:
canadaspremiers.ca/contact-a-p
Invivyd Contact Information
Email: info@invivyd.com
Phone: 800-890-3385
Monday-Friday, 9:00 AM to 7:00 PM ET
#BringPemgardaToCanada
#Protectimmunocompromised
#COVID-19|sNotOver
#MAbsForCanadaNOW

Change.orgSign the PetitionMake Monoclonal Antibodies for COVID-19 Available in Canada Now
Public
💉💉💉💉💉💉💉💉 🗿😷:antiverified:

RT @EckerleIsabella@x.com: »My opinion & I will die on this hill: The current anti-vaccine movement will have a major impact on women and will reverse women's rights. When women have to produce extra babies because 1 in 5 will not survive, they will not have energy or time to fight for equality anymore.

While being pregnant, postpartum, caring for many children, caring for a sick child, grieving deceased ones & fearing their siblings dying as well, women will be drained of energy & will not fight oppression. Without vaccines, a lot of healthy children will not survive their early childhood period.

In addition, not providing vaccines will disproportionally affect vulnerable children: While many perfectly healthy children will die, those with underlying conditions are even at higher risk. Not protecting them will shorten their life. We've seen it already during Covid.

I just want to stress this: Most of society is not aware in which a luxury situation vaccines has put parents in only the last few decades, that is, not seeing your young children die. If you don't believe me, read books about the polio period, or visit an old graveyard. It's all there.«

#vaccines#vaccinate#measles
ExplorerFlux en direct
À propos